INTRODUCTION

            1.1.       SCOPE OF THE STUDY

            1.2.       THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

            1.3.       MARKET SEGMENTATION

                         1.3.1   Cancer Vaccines Market - By Technology

                         1.3.2   Cancer Vaccines Market - By Type

                   1.3.3   Cancer Vaccines Market - By Indication

                         1.3.4   Cancer Vaccines Market - By End User

                         1.3.5   Cancer Vaccines Market - By Country

2.        KEY TAKEAWAYS

3.        RESEARCH METHODOLOGY

4.        CANCER VACCINES MARKET LANDSCAPE

            4.1.       OVERVIEW

            4.2.       PEST ANALYSIS

                         4.2.1        MIDDLE EAST AND AFRICA - Pest Analysis

            4.3.       EXPERT OPINIONS

5.        CANCER VACCINES MARKET - KEY MARKET DYNAMICS

            5.1.       KEY MARKET DRIVERS

            5.2.       KEY MARKET RESTRAINTS

            5.3.       KEY MARKET OPPORTUNITIES

            5.4.       FUTURE TRENDS

            5.5.       IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.        CANCER VACCINES MARKET - MIDDLE EAST AND AFRICA MARKET ANALYSIS

            6.1.       CANCER VACCINES - MIDDLE EAST AND AFRICA MARKET OVERVIEW

            6.2.       CANCER VACCINES - MIDDLE EAST AND AFRICA MARKET AND FORECAST TO 2027

            6.3.       MARKET POSITIONING/MARKET SHARE

7.        CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – TECHNOLOGY

            7.1.       OVERVIEW

            7.2.       TECHNOLOGY MARKET FORECASTS AND ANALYSIS

            7.3.       DENDRITIC CELLS CANCER VACCINES

                          7.3.1.         Overview

                          7.3.2.         Dendritic Cells Cancer Vaccines Market Forecast and Analysis

            7.4.       RECOMBINANT CANCER VACCINES

                          7.4.1.         Overview

                          7.4.2.         Recombinant Cancer Vaccines Market Forecast and Analysis

            7.5.       ANTIGEN CANCER VACCINES

                          7.5.1.         Overview

                          7.5.2.         Antigen Cancer Vaccines Market Forecast and Analysis

            7.6.       WHOLE CELL CANCER VACCINES

                          7.6.1.         Overview

                   7.6.2.         Whole Cell Cancer Vaccines Market Forecast and Analysis

            7.7.       VIRAL VECTOR CANCER VACCINES

                          7.7.1.         Overview

                          7.7.2.         Viral Vector Cancer Vaccines Market Forecast and Analysis

8.        CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – TYPE

            8.1.       OVERVIEW

            8.2.       TYPE MARKET FORECASTS AND ANALYSIS

            8.3.       PREVENTIVE CANCER VACCINES

                 8.3.1.         Overview

                          8.3.2.         Preventive Cancer Vaccines Market Forecast and Analysis

            8.4.       THERAPEUTIC CANCER VACCINES

                          8.4.1.         Overview

                          8.4.2.         Therapeutic Cancer Vaccines Market Forecast and Analysis

9.        CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – INDICATION

            9.1.       OVERVIEW

            9.2.       INDICATION MARKET FORECASTS AND ANALYSIS

            9.3.       CERVICAL CANCER

                          9.3.1.         Overview

                          9.3.2.         Cervical Cancer Market Forecast and Analysis

            9.4.       PROSTATE CANCER

                          9.4.1.         Overview

                          9.4.2.         Prostate Cancer Market Forecast and Analysis

            9.5.       OTHER INDICATIONS

                          9.5.1.         Overview

                     9.5.2.         Other Indications Market Forecast and Analysis

10.        CANCER VACCINES MARKET - REVENUE AND FORECASTS TO 2027 – END USER

               10.1.       OVERVIEW

               10.2.       END USER MARKET FORECASTS AND ANALYSIS

               10.3.       PEDIATRICS

                             10.3.1.         Overview

                             10.3.2.         Pediatrics Market Forecast and Analysis

               10.4.       ADULTS

                             10.4.1.         Overview

                             10.4.2.         Adults Market Forecast and Analysis

11.        CANCER VACCINES MARKET REVENUE AND FORECASTS TO 2027 – COUNTRY ANALYSIS

1. 1. 11.1      MIDDLE EAST AND AFRICA CANCER VACCINES MARKET OVERVIEW
   2. 11.2      MIDDLE EAST AND AFRICA CANCER VACCINES MARKET FORECASTS AND ANALYSIS
   3. 11.3      MIDDLE EAST AND AFRICA Cancer Vaccines Market FORECASTS AND ANALYSIS - BY COUNTRIES

                              11.3.1     UAE Cancer Vaccines Market

1. • 11.3.1.1   UAE Cancer Vaccines Market by Technology
   • 11.3.1.2   UAE Cancer Vaccines Market by Type
   • 11.3.1.3   UAE Cancer Vaccines Market by Indication
   • 11.3.1.4   UAE Cancer Vaccines Market by End User

                              11.3.2     Saudi Arabia Cancer Vaccines Market

2. • 11.3.2.1   Saudi Arabia Cancer Vaccines Market by Technology
   • 11.3.2.2   Saudi Arabia Cancer Vaccines Market by Type
   • 11.3.2.3   Saudi Arabia Cancer Vaccines Market by Indication
   • 11.3.2.4   Saudi Arabia Cancer Vaccines Market by End User

                              11.3.3     South Africa Cancer Vaccines Market

3. • 11.3.3.1   South Africa Cancer Vaccines Market by Technology
   • 11.3.3.2   South Africa Cancer Vaccines Market by Type
   • 11.3.3.3   South Africa Cancer Vaccines Market by Indication
   • 11.3.3.4   South Africa Cancer Vaccines Market by End User

13.        INDUSTRY LANDSCAPE

               13.1.       MERGERS AND ACQUISITIONS

               13.2.       AGREEMENTS, COLLABORATIONS AND JOINT VENTURES

               13.3.       NEW PRODUCT LAUNCHES

               13.4.       EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14.        CANCER VACCINES MARKET, KEY COMPANY PROFILES

               14.1.     ASTRAZENECA

                              14.1.1.      Key Facts

                              14.1.2.      Business Description

                              14.1.3.      Products and Services

                              14.1.4.      Financial Overview

                              14.1.5.      SWOT Analysis

                              14.1.6.      Key Developments

               14.2.     GLAXOSMITHKLINE PLC.

                              14.2.1.      Key Facts

                              14.2.2.      Business Description

                              14.2.3.      Products and Services

               14.2.4.      Financial Overview

                              14.2.5.      SWOT Analysis

                              14.2.6.      Key Developments

               14.3.     ADURO BIOTECH INC

                              14.3.1.      Key Facts

                              14.3.2.      Business Description

                              14.3.3.      Products and Services

                              14.3.4.      Financial Overview

                              14.3.5.      SWOT Analysis

                              14.3.6.      Key Developments

               14.4.     PFIZER INC.

                              14.4.1.      Key Facts

                              14.4.2.      Business Description

                              14.4.3.      Products and Services

                              14.4.4.      Financial Overview

                              14.4.5.      SWOT Analysis

                              14.4.6.      Key Developments

               14.5.     SANOFI

        14.5.1.      Key Facts

                              14.5.2.      Business Description

                              14.5.3.      Products and Services

                              14.5.4.      Financial Overview

                              14.5.5.      SWOT Analysis

                              14.5.6.      Key Developments

               14.6.     BRISTOL-MYERS SQUIBB

                              14.6.1.      Key Facts

                              14.6.2.      Business Description

                    14.6.3.      Products and Services

                              14.6.4.      Financial Overview

                              14.6.5.      SWOT Analysis

                              14.6.6.      Key Developments

               14.7.     MODERNA, INC.

                              14.7.1.      Key Facts

                              14.7.2.      Business Description

                              14.7.3.      Products and Services

                              14.7.4.      Financial Overview

                              14.7.5.      SWOT Analysis

                              14.7.6.      Key Developments

               14.8.     ONCBIOMUNE PHARMACEUTICALS INC.

                              14.8.1.      Key Facts

                              14.8.2.      Business Description

                              14.8.3.      Products and Services

             14.8.4.      Financial Overview

                              14.8.5.      SWOT Analysis

                              14.8.6.      Key Developments

               14.9.     MAXIVAX

                              14.9.1.      Key Facts

                      14.9.2.      Business Description

                              14.9.3.      Products and Services

                              14.9.4.      Financial Overview

                              14.9.5.      SWOT Analysis

              14.9.6.      Key Developments

               14.10.     NOUSCOM

                              14.10.1.      Key Facts

                              14.10.2.      Business Description

                              14.10.3.      Products and Services

                              14.10.4.      Financial Overview

                              14.10.5.      SWOT Analysis

                              14.10.6.      Key Developments

15.        APPENDIX

               15.1.       ABOUT THE INSIGHT PARTNERS

               15.2.       GLOSSARY OF TERMS

LIST OF TABLES

Table 1. Middle East & Africa Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East & Africa Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 3. Middle East & Africa Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 4. Middle East & Africa Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Saudi Arabia Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Saudi Arabia Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 7. Saudi Arabia Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 8. Saudi Arabia Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 9. UAE Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 10. UAE Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 11. UAE Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 12. UAE Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. South Africa Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. South Africa Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 15. South Africa Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 16. South Africa Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Cancer Vaccines Market
 

LIST OF FIGURES
Figure 1. Cancer Vaccines Market Segmentation
Figure 2. Cancer Vaccines Market Segmentation, By Region
Figure 3. Cancer Vaccines Market Overview
Figure 4. Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market
Figure 5. MEA Cancer Vaccines market, Industry Landscape
Figure 6. Middle East and Africa (MEA) PEST Analysis
Figure 7. Cancer Statistics, 2020
Figure 8. Cancer Vaccines Market Impact Analysis of Driver and Restraints
Figure 9. Cancer Vaccines Market, by Technology, 2019 and 2027 (%)
Figure 10. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
Figure 16. Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
Figure 19. Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
Figure 23. Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Middle East & Africa: Cancer Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 26. Middle East & Africa Cancer Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 27. Middle East & Africa: Cancer Vaccines Market Share by Country – 2019 & 2027, (%)
Figure 28. Saudi Arabia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. UAE: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. South Africa: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Impact of COVID-19 Pandemic in Rest of World Country Markets
Figure 32. Growth Strategies Done by the Companies in the Market, (%)